Almac Says It’s on Schedule to Launch Colorectal, Lung Cancer Tests in ’09, ’10

The tests run on Affymetrix’s GeneChip platform to identify gene-expression signatures linked to colorectal cancer recurrence and early-stage lung cancer. A third test, for early-stage breast cancer detection, is also under development, though no launch date has been set.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.